# Study to Evaluate the Fecal Microbiota Transplantation (FMT) in the Treatment of Ulcerative Colitis

> **NCT05786404** · PHASE1 · RECRUITING · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 20 (estimated)

## Conditions studied

- Active Ulcerative Colitis (UC)

## Interventions

- **DRUG:** PRIM-DJ2727 - FROZEN
- **DRUG:** PRIM-DJ2727 - CAPSULES

## Key facts

- **NCT ID:** NCT05786404
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-15
- **Primary completion:** 2026-12-15
- **Final completion:** 2027-12-15
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05786404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05786404, "Study to Evaluate the Fecal Microbiota Transplantation (FMT) in the Treatment of Ulcerative Colitis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05786404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*